Disclosures for "Depressive Symptoms are Associated with APOE4 Carrier Status and Anti-Seizure Medication Polytherapy in Late-Onset Unexplained Epilepsy"
-
Mr. Sadek has nothing to disclose.
-
Miss Hankerson has nothing to disclose.
-
Ms. Orozco has nothing to disclose.
-
Ms. Amariglio has nothing to disclose.
-
The institution of Dr. Pennell has received research support from NIH. Dr. Pennell has received publishing royalties from a publication relating to health care.
-
Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma USA Inc. Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beth Israel Deaconness Medical Center. Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Harvard Health Publications.
-
Dr. Sarkis has nothing to disclose.